ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Insulin Glargine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-2316
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Insulin Glargine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Insulin Glargine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-2316
Report
May 2025
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Aventis
Ganlee
Biocon Ltd.

Insulin Glargine Market Size

In 2024, the global market size of Insulin Glargine was estimated to be worth US$ 7251 million and is forecast to reach approximately US$ 9505 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.

Insulin Glargine Market

Insulin Glargine Market

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
Global Insulin Glargine key players include Sanofi-Aventis, Ganlee, etc. Global top two manufacturers hold a share nearly 50%.
USA is the largest market, with a share over 60%, followed by China, and Europe, both have a share about 35 percent.
In terms of product, Pre-filled Syringe is the largest segment, with a share about 75%. And in terms of application, the largest application is Treat type2 diabetes, followed by Treat type1 diabetes.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin Glargine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Glargine.
The Insulin Glargine market size, estimations, and forecasts are provided in terms of sales volume (M mL) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insulin Glargine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Glargine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Insulin Glargine Market Report

Report Metric Details
Report Name Insulin Glargine Market
CAGR 4.0%
Segment by Type
  • Single Dose Vial
  • Pre-filled Syringe
Segment by Application
  • Treat Type2 Diabetes
  • Treat Type1 Diabetes
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi-Aventis, Ganlee, Biocon
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Insulin Glargine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Insulin Glargine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insulin Glargine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in Insulin Glargine Market?

Ans: Global top two manufacturers hold a share nearly 50%.

What is the Insulin Glargine Market share by type?

Ans: In terms of product, Pre-filled Syringe is the largest segment, with a share about 75%.

Who are the main players in the Insulin Glargine Market report?

Ans: The main players in the Insulin Glargine Market are Sanofi-Aventis, Ganlee, Biocon

What are the Application segmentation covered in the Insulin Glargine Market report?

Ans: The Applications covered in the Insulin Glargine Market report are Treat Type2 Diabetes, Treat Type1 Diabetes

What are the Type segmentation covered in the Insulin Glargine Market report?

Ans: The Types covered in the Insulin Glargine Market report are Single Dose Vial, Pre-filled Syringe

Recommended Reports

Insulin Delivery Devices

Antidiabetic Medications

Insulin Injectables & Syringes

Market trends :

Topic Trends
Global the insulin glargine market is experiencing growth driven by increasing adoption of pre-filled syringes and rising prevalence of type 2 diabetes globally.
Type Single Dose Vial - demand for single dose vials remains steady, but growth is outpaced by pre-filled syringes due to convenience and patient preference.
Pre-filled Syringe - pre-filled syringes dominate the insulin glargine market, capturing approximately 75% share due to ease of use and improved patient compliance.
Application Treat Type2 Diabetes - insulin glargine usage for treating type 2 diabetes continues to rise, representing the largest application segment globally.
Treat Type1 Diabetes - insulin glargine remains a critical therapy for type 1 diabetes, though its market share is smaller compared to type 2 diabetes applications.
Company Sanofi-Aventis - sanofi-aventis maintains a leading position in the insulin glargine market through continuous product innovation and broad geographic presence.
Ganlee - ganlee strengthens its market share in asia-pacific by expanding distribution of insulin glargine products.
Biocon - biocon leverages strategic partnerships to enhance its global reach for insulin glargine formulations.
Region North America - north america leads the global insulin glargine market, driven by high diabetes prevalence and advanced healthcare infrastructure.
EMEA - emea region sees steady growth in insulin glargine adoption, supported by increasing awareness and healthcare access.
APAC - apac market for insulin glargine expands rapidly, fueled by rising diabetes rates and improved distribution networks.
LATAM - latam experiences moderate growth in insulin glargine demand, with opportunities emerging from expanding healthcare coverage.
1 Study Coverage
1.1 Insulin Glargine Product Introduction
1.2 Market by Type
1.2.1 Global Insulin Glargine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Market by Application
1.3.1 Global Insulin Glargine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Treat Type2 Diabetes
1.3.3 Treat Type1 Diabetes
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin Glargine Market Size Estimates and Forecasts
2.1.1 Global Insulin Glargine Revenue 2020-2031
2.1.2 Global Insulin Glargine Sales 2020-2031
2.2 Insulin Glargine Market Size by Region: 2024 Versus 2031
2.3 Insulin Glargine Sales by Region (2020-2031)
2.3.1 Global Insulin Glargine Sales by Region: 2020-2025
2.3.2 Global Insulin Glargine Sales Forecast by Region (2026-2031)
2.3.3 Global Insulin Glargine Sales Market Share by Region (2020-2031)
2.4 Insulin Glargine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Insulin Glargine Revenue by Region: 2020-2025
2.4.2 Global Insulin Glargine Revenue Forecast by Region (2026-2031)
2.4.3 Global Insulin Glargine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Insulin Glargine Sales by Type (2020-2031)
3.1.1.1 Global Insulin Glargine Sales Volume by Type (2020-2031)
3.1.1.2 Global Insulin Glargine Sales Market Share by Type (2020-2031)
3.1.2 Global Insulin Glargine Revenue by Type (2020-2031)
3.1.2.1 Global Insulin Glargine Revenue by Type (2020-2031)
3.1.2.2 Global Insulin Glargine Revenue Market Share by Type (2020-2031)
3.1.3 Insulin Glargine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Insulin Glargine Sales by Application (2020-2031)
3.2.1.1 Global Insulin Glargine Sales Volume by Application (2020-2031)
3.2.1.2 Global Insulin Glargine Sales Market Share by Application (2020-2031)
3.2.2 Global Insulin Glargine Revenue by Application (2020-2031)
3.2.2.1 Global Insulin Glargine Revenue by Application (2020-2031)
3.2.2.2 Global Insulin Glargine Revenue Market Share by Application (2020-2031)
3.2.3 Insulin Glargine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Single Dose Vial of Insulin Glargine Revenue Market Share by Application
3.3.2 Pre-filled Syringe of Insulin Glargine Revenue Market Share by Application
4 Global Insulin Glargine by Manufacturers
4.1 Global Top Insulin Glargine Manufacturers by Sales (2020-2025)
4.1.1 Global Insulin Glargine Sales by Manufacturer (2020-2025)
4.1.2 Global Insulin Glargine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Insulin Glargine Manufacturers by Revenue (2020-2025)
4.2.1 Global Insulin Glargine Revenue by Manufacturer (2020-2025)
4.2.2 Global Insulin Glargine Revenue Share by Manufacturer (2020-2025)
4.3 Global Insulin Glargine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Insulin Glargine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Insulin Glargine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Insulin Glargine Manufacturing Base Distribution, Product Type
4.5.1 Insulin Glargine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Insulin Glargine Market
4.5.3 Manufacturers Insulin Glargine Product Type and Application
4.5.4 Single Dose Vial Market Sales of Insulin Glargine by Manufacturer
4.5.5 Pre-filled Syringe Market Sales of Insulin Glargine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sanofi-Aventis
5.1.1 Sanofi-Aventis Company Information
5.1.2 Sanofi-Aventis Description, Business Overview
5.1.3 Sanofi-Aventis Insulin Glargine Products Offered
5.1.4 Sanofi-Aventis Insulin Glargine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Sanofi-Aventis Insulin Glargine Sales by Product in 2024
5.1.6 Sanofi-Aventis Insulin Glargine Sales by Application in 2024
5.1.7 Sanofi-Aventis Insulin Glargine Sales by Geographic Area in 2024
5.1.8 Sanofi-Aventis Recent Developments
5.2 Ganlee
5.2.1 Ganlee Company Information
5.2.2 Ganlee Description, Business Overview
5.2.3 Ganlee Insulin Glargine Products Offered
5.2.4 Ganlee Insulin Glargine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Ganlee Insulin Glargine Sales by Product in 2024
5.2.6 Ganlee Insulin Glargine Sales by Application in 2024
5.2.7 Ganlee Insulin Glargine Sales by Geographic Area in 2024
5.2.8 Ganlee Recent Developments
5.3 Biocon
5.3.1 Biocon Company Information
5.3.2 Biocon Description, Business Overview
5.3.3 Biocon Insulin Glargine Products Offered
5.3.4 Biocon Insulin Glargine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Biocon Insulin Glargine Sales by Product in 2024
5.3.6 Biocon Insulin Glargine Sales by Application in 2024
5.3.7 Biocon Insulin Glargine Sales by Geographic Area in 2024
5.3.8 Biocon Recent Developments
6 North America
6.1 North America Insulin Glargine Market Size YoY Growth 2020-2031
6.2 North America Insulin Glargine Market Facts & Figures by Country
6.2.1 North America Insulin Glargine Sales by Country (2020-2031)
6.2.2 North America Insulin Glargine Revenue by Country (2020-2031)
6.3 North America Insulin Glargine Sales by Type (2020-2025)
6.4 North America Insulin Glargine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Insulin Glargine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Insulin Glargine Market Facts & Figures by Region
7.2.1 Asia-Pacific Insulin Glargine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Insulin Glargine Revenue by Region (2020-2031)
7.3 Asia-Pacific Insulin Glargine Sales by Type (2020-2025)
7.4 Asia-Pacific Insulin Glargine Sales by Application (2020-2025)
8 Europe
8.1 Europe Insulin Glargine Market Size YoY Growth 2020-2031
8.2 Europe Insulin Glargine Market Facts & Figures by Country
8.2.1 Europe Insulin Glargine Sales by Country (2020-2031)
8.2.2 Europe Insulin Glargine Revenue by Country (2020-2031)
8.3 Europe Insulin Glargine Sales by Type (2020-2025)
8.4 Europe Insulin Glargine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Insulin Glargine Market Size YoY Growth 2020-2031
9.2 Latin America Insulin Glargine Market Facts & Figures by Country
9.2.1 Latin America Insulin Glargine Sales by Country (2020-2031)
9.2.2 Latin America Insulin Glargine Revenue by Country (2020-2031)
9.3 Latin America Insulin Glargine Sales by Type (2020-2025)
9.4 Latin America Insulin Glargine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Insulin Glargine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Insulin Glargine Market Facts & Figures by Country
10.2.1 Middle East and Africa Insulin Glargine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Insulin Glargine Revenue by Country (2020-2031)
10.3 Middle East and Africa Insulin Glargine Sales by Type (2020-2025)
10.4 Middle East and Africa Insulin Glargine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Insulin Glargine Supply Chain Analysis
11.2 Insulin Glargine Key Raw Materials and Upstream Suppliers
11.3 Insulin Glargine Clients Analysis
11.4 Insulin Glargine Sales Channel and Sales Model Analysis
11.4.1 Insulin Glargine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Insulin Glargine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Insulin Glargine Distributors
12 Insulin Glargine Market Dynamics
12.1 Insulin Glargine Industry Trends
12.2 Insulin Glargine Market Drivers
12.3 Insulin Glargine Market Challenges
12.4 Insulin Glargine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Sanofi Aventis
Ganlee
Biocon Ltd.
List of Tables
 Table 1. Global Insulin Glargine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Insulin Glargine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Insulin Glargine Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Insulin Glargine Sales by Region (2020-2025) & (M mL)
 Table 5. Global Insulin Glargine Sales Forecast by Region (2026-2031) & (M mL)
 Table 6. Global Insulin Glargine Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Insulin Glargine Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Insulin Glargine Sales Volume by Type (2020-2025) & (M mL)
 Table 9. Global Insulin Glargine Sales Volume by Type (2026-2031) & (M mL)
 Table 10. Global Insulin Glargine Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Insulin Glargine Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Insulin Glargine Sales Volume by Application (2020-2025) & (M mL)
 Table 13. Global Insulin Glargine Sales Volume by Application (2026-2031) & (M mL)
 Table 14. Global Insulin Glargine Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Insulin Glargine Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Insulin Glargine Sales by Manufacturer (2020-2025) & (M mL)
 Table 17. Global Insulin Glargine Sales Share by Manufacturer (2020-2025)
 Table 18. Insulin Glargine Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Insulin Glargine Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Insulin Glargine Price (2020-2025) & (USD/mL)
 Table 21. Ranking of Global Top Insulin Glargine Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Insulin Glargine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Insulin Glargine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Glargine as of 2024)
 Table 24. Insulin Glargine Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Insulin Glargine Market
 Table 26. Manufacturers Insulin Glargine Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Sanofi-Aventis Company Information
 Table 29. Sanofi-Aventis Description and Business Overview
 Table 30. Sanofi-Aventis Insulin Glargine Product
 Table 31. Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2020-2025)
 Table 32. Sanofi-Aventis Sales Proportion of Insulin Glargine by Product in 2024
 Table 33. Sanofi-Aventis Sales Proportion of Insulin Glargine by Application in 2024
 Table 34. Sanofi-Aventis Sales Proportion of Insulin Glargine by Geographic Area in 2024
 Table 35. Sanofi-Aventis Recent Developments
 Table 36. Ganlee Company Information
 Table 37. Ganlee Description and Business Overview
 Table 38. Ganlee Insulin Glargine Product
 Table 39. Ganlee Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2020-2025)
 Table 40. Ganlee Sales Proportion of Insulin Glargine by Product in 2024
 Table 41. Ganlee Sales Proportion of Insulin Glargine by Application in 2024
 Table 42. Ganlee Sales Proportion of Insulin Glargine by Geographic Area in 2024
 Table 43. Ganlee Recent Developments
 Table 44. Biocon Company Information
 Table 45. Biocon Description and Business Overview
 Table 46. Biocon Insulin Glargine Product
 Table 47. Biocon Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2020-2025)
 Table 48. Biocon Sales Proportion of Insulin Glargine by Product in 2024
 Table 49. Biocon Sales Proportion of Insulin Glargine by Application in 2024
 Table 50. Biocon Sales Proportion of Insulin Glargine by Geographic Area in 2024
 Table 51. Biocon Recent Developments
 Table 52. North America Insulin Glargine Sales by Country (2020-2025) & (M mL)
 Table 53. North America Insulin Glargine Sales by Country (2026-2031) & (M mL)
 Table 54. North America Insulin Glargine Revenue by Country (2020-2025) & (US$ Million)
 Table 55. North America Insulin Glargine Revenue by Country (2026-2031) & (US$ Million)
 Table 56. North America Insulin Glargine Sales by Type (2020-2025) & (M mL)
 Table 57. North America Insulin Glargine Sales by Application (2020-2025) & (M mL)
 Table 58. Asia-Pacific Insulin Glargine Sales by Region (2020-2025) & (M mL)
 Table 59. Asia-Pacific Insulin Glargine Sales by Region (2026-2031) & (M mL)
 Table 60. Asia-Pacific Insulin Glargine Revenue by Region (2020-2025) & (US$ Million)
 Table 61. Asia-Pacific Insulin Glargine Revenue by Region (2026-2031) & (US$ Million)
 Table 62. Asia-Pacific Insulin Glargine Sales by Type (2020-2025) & (M mL)
 Table 63. Asia-Pacific Insulin Glargine Sales by Application (2020-2025) & (M mL)
 Table 64. Europe Insulin Glargine Sales by Country (2020-2025) & (M mL)
 Table 65. Europe Insulin Glargine Sales by Country (2026-2031) & (M mL)
 Table 66. Europe Insulin Glargine Revenue by Country (2020-2025) & (US$ Million)
 Table 67. Europe Insulin Glargine Revenue by Country (2026-2031) & (US$ Million)
 Table 68. Europe Insulin Glargine Sales by Type (2020-2025) & (M mL)
 Table 69. Europe Insulin Glargine Sales by Application (2020-2025) & (M mL)
 Table 70. Latin America Insulin Glargine Sales by Country (2020-2025) & (M mL)
 Table 71. Latin America Insulin Glargine Sales by Country (2026-2031) & (M mL)
 Table 72. Latin America Insulin Glargine Revenue by Country (2020-2025) & (US$ Million)
 Table 73. Latin America Insulin Glargine Revenue by Country (2026-2031) & (US$ Million)
 Table 74. Latin America Insulin Glargine Sales by Type (2020-2025) & (M mL)
 Table 75. Latin America Insulin Glargine Sales by Application (2020-2025) & (M mL)
 Table 76. Middle East and Africa Insulin Glargine Sales by Country (2020-2025) & (M mL)
 Table 77. Middle East and Africa Insulin Glargine Sales by Country (2026-2031) & (M mL)
 Table 78. Middle East and Africa Insulin Glargine Revenue by Country (2020-2025) & (US$ Million)
 Table 79. Middle East and Africa Insulin Glargine Revenue by Country (2026-2031) & (US$ Million)
 Table 80. Middle East and Africa Insulin Glargine Sales by Type (2020-2025) & (M mL)
 Table 81. Middle East and Africa Insulin Glargine Sales by Application (2020-2025) & (M mL)
 Table 82. Insulin Glargine Key Raw Materials, Industry Status and Trend
 Table 83. Insulin Glargine Key Raw Materials and Upstream Suppliers
 Table 84. Insulin Glargine Clients Status and Trend
 Table 85. Insulin Glargine Typical Clients
 Table 86. Insulin Glargine Distributors
 Table 87. Insulin Glargine Market Trends
 Table 88. Insulin Glargine Market Drivers
 Table 89. Insulin Glargine Market Challenges
 Table 90. Insulin Glargine Market Restraints
 Table 91. Research Programs/Design for This Report
 Table 92. Key Data Information from Secondary Sources
 Table 93. Key Data Information from Primary Sources
 Table 94. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Insulin Glargine Product Picture
 Figure 2. Global Insulin Glargine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Insulin Glargine Sales Market Share by Type in 2024 & 2031
 Figure 4. Single Dose Vial Product Picture
 Figure 5. Pre-filled Syringe Product Picture
 Figure 6. Global Insulin Glargine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Insulin Glargine Sales Market Share by Application in 2024 & 2031
 Figure 8. Treat Type2 Diabetes
 Figure 9. Treat Type1 Diabetes
 Figure 10. Insulin Glargine Report Years Considered
 Figure 11. Global Insulin Glargine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Insulin Glargine Market Size 2020-2031 (US$ Million)
 Figure 13. Global Insulin Glargine Sales 2020-2031 (M mL)
 Figure 14. Global Insulin Glargine Sales Market Share Forecast by Region (2020-2031)
 Figure 15. Global Insulin Glargine Revenue Market Share by Region (2020-2031)
 Figure 16. Global Insulin Glargine Sales Market Share Forecast by Type (2020-2031)
 Figure 17. Global Insulin Glargine Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Insulin Glargine Average Selling Price (ASP) by Type (2020-2025) & (USD/mL)
 Figure 19. Global Insulin Glargine Sales Market Share Forecast by Application (2020-2031)
 Figure 20. Global Insulin Glargine Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. Insulin Glargine Average Selling Price (ASP) by Application (2020-2025) & (USD/mL)
 Figure 22. Single Dose Vial of Insulin Glargine Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Pre-filled Syringe of Insulin Glargine Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Global Insulin Glargine Sales Share by Manufacturer in 2024
 Figure 25. Insulin Glargine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Single Dose Vial Market Sales Proportion by Manufacturer in 2024
 Figure 27. Pre-filled Syringe Market Sales Proportion by Manufacturer in 2024
 Figure 28. North America Insulin Glargine Revenue 2020-2031 (US$ Million)
 Figure 29. North America Insulin Glargine Sales Market Share by Type (2020-2025)
 Figure 30. North America Insulin Glargine Sales Market Share by Application (2020-2025)
 Figure 31. Asia-Pacific Insulin Glargine Revenue 2020-2031 (US$ Million)
 Figure 32. Asia-Pacific Insulin Glargine Sales Market Share by Region (2020-2031)
 Figure 33. Asia-Pacific Insulin Glargine Revenue Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Insulin Glargine Sales Market Share by Type (2020-2025)
 Figure 35. Asia-Pacific Insulin Glargine Sales Market Share by Application (2020-2025)
 Figure 36. Europe Insulin Glargine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Europe Insulin Glargine Sales Market Share by Country (2020-2031)
 Figure 38. Europe Insulin Glargine Revenue Market Share by Country (2020-2031)
 Figure 39. Europe Insulin Glargine Sales Market Share by Type (2020-2025)
 Figure 40. Europe Insulin Glargine Sales Market Share by Application (2020-2025)
 Figure 41. Latin America Insulin Glargine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America Insulin Glargine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Insulin Glargine Revenue Market Share by Country (2020-2025)
 Figure 44. Latin America Insulin Glargine Sales Market Share by Type (2020-2025)
 Figure 45. Latin America Insulin Glargine Sales Market Share by Application (2020-2025)
 Figure 46. Middle East and Africa Insulin Glargine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Middle East and Africa Insulin Glargine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Insulin Glargine Revenue Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Insulin Glargine Sales Market Share by Type (2020-2025)
 Figure 50. Middle East and Africa Insulin Glargine Sales Market Share by Application (2020-2025)
 Figure 51. Insulin Glargine Supply Chain (Upstream and Downstream Market)
 Figure 52. Global Production Market Share of Insulin Glargine Raw Materials by Region in 2024
 Figure 53. Insulin Glargine Distribution Channels
 Figure 54. Global Insulin Glargine Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 55. Global Insulin Glargine Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Basal Insulin Long Acting Insulin Market
Liraglutide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biosimilar Insulin Glargine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin Glargine and Lispro Market Research Report 2024
Global Long Acting Insulins Market Insights Forecast to 2030
Global Insulin Glargine Injection Market Research Report 2024
Global Long Acting Insulin Analogue Market Research Report 2025
Global Insulin Drugs for Diabetes Market Research Report 2024
Lanreotide Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Premixed Insulin Market Research Report 2024
Global Insulin Lancing Device Market Research Report 2025
Global Insulin Lispro Market Research Report 2024
Global Premixed Insulin Analogs Market Research Report 2024
Global Short acting Insulin Market Research Report 2024
Global Rapid Acting Insulins Market Insights Forecast to 2030
Global Fast Acting Insulin Analog Market Research Report 2025
Gliclazide Sustained release Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Metformin Hydrochloride Sustained release Tablets Market Research Report 2024
Global Premix Insulin Market Insights Forecast to 2030
Global Ultra Long Acting Insulin Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions